tesaglitazar associated_with type 2 diabetes

Subject: tesaglitazar
Relation: associated_with
Object: type 2 diabetes
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013) PMID:24285952 cited

effects of tesaglitazar ... have generally proven to be predictive of effects in patients with type 2 diabetes

confidence: 0.90